Evaluation of cytokine mRNA expression in bronchoalveolar lavage cells from horses with inflammatory airway disease.

This research article investigates the role of certain cytokines in the inflammatory airway disease (IAD) in horses, a condition associated with poor performance and accumulation of mucus and inflammatory cells in the animal’s lower airway secretions. The study compares the gene expression of various cytokines in the bronchoalveolar lavage fluid of horses suffering from IAD against healthy horses.

Objective of the Study

• This study aims to understand the molecular pathways and immune system’s role in the development of Inflammatory airway disease (IAD) in horses. Specifically, it examines the gene expression of different cytokines in bronchoalveolar lavage fluid (BALF) of horses with IAD and compares it with healthy horses.

Methodology

• The study looked at 21 horses diagnosed with IAD and 17 horses free from respiratory tract diseases. The researchers extracted cell pellets from the bronchoalveolar lavage fluid of these horses and compared the mRNA expression of various cytokines – TNF-α, IFN-γ, IL-1β, IL-2, IL-4, IL-8, IL-13, IL-17, and IL-23.

Results

• Findings show that horses with IAD had substantially higher levels of TNF-α, IL-1β, and IL-23 mRNA. This suggests that IAD in horses might be associated with enhanced mRNA expression of pro-inflammatory cytokines in BALF cells, possibly indicating the stimulation of innate immune responses to inhaled antigens.
• No significant differences were noted in the expression of other cytokine mRNAs.

Interpretation and Conclusion

• The study indicates an increase in levels of certain pro-inflammatory cytokines in horses with IAD, which may mean innate immune responses are triggered by inhaled antigens.
• Interestingly, the findings do not show a polarised T-cell cytokine response. This suggests that hypersensitivity responses might not be a factor in the aetiopathogenesis of IAD, different from conditions like equine recurrent airway obstruction and human asthma.
• The study’s insights could potentially lead to a deeper understanding of the aetiopathological pathway(s) involved in IAD and contribute towards developing new treatment methods.